AI Co-Pilot aims to sharpen eye disease diagnoses
NCT ID NCT07401459
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an AI tool called EyeAgent that helps eye doctors make decisions. About 300 people visiting eye clinics in Hong Kong and mainland China will take part. The AI reviews patient images and history to suggest diagnoses and treatments. The goal is to see if using the AI improves accuracy, efficiency, and doctor satisfaction compared to standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AI AGENT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Hong Kong Polytechnic University
Hong Kong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can AI outthink cancer experts? a landmark trial pits five AIs against tumor boards
- AI that asks questions first may help people triage symptoms more accurately
- AI tutor for kidney doctors: can a chatbot improve dialysis decisions?
- Could a smartphone camera spot blinding eye diseases?
- Could stem cells restore sight in damaged eyes?
- New eye scanner aims to sharpen view of retinal disease